These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
494 related articles for article (PubMed ID: 11139438)
1. The effect of selective and non-selective phosphodiesterase inhibitors on allergen- and leukotriene C(4)-induced contractions in passively sensitized human airways. Schmidt DT; Watson N; Dent G; Rühlmann E; Branscheid D; Magnussen H; Rabe KF Br J Pharmacol; 2000 Dec; 131(8):1607-18. PubMed ID: 11139438 [TBL] [Abstract][Full Text] [Related]
2. Airway relaxant and anti-inflammatory properties of a PDE4 inhibitor with low affinity for the high-affinity rolipram binding site. Martin C; Göggel R; Dal Piaz V; Vergelli C; Giovannoni P; Ernst M; Uhlig S Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):284-9. PubMed ID: 11919652 [TBL] [Abstract][Full Text] [Related]
3. PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries. Santos-Silva AJ; Cairrão E; Morgado M; Alvarez E; Verde I Eur J Pharmacol; 2008 Mar; 582(1-3):102-9. PubMed ID: 18234184 [TBL] [Abstract][Full Text] [Related]
4. Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions. Hatzelmann A; Tenor H; Schudt C Br J Pharmacol; 1995 Feb; 114(4):821-31. PubMed ID: 7539697 [TBL] [Abstract][Full Text] [Related]
5. In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor-alpha release by PDE inhibitors. Gantner F; Kupferschmidt R; Schudt C; Wendel A; Hatzelmann A Br J Pharmacol; 1997 May; 121(2):221-31. PubMed ID: 9154331 [TBL] [Abstract][Full Text] [Related]
7. Identification of PDE isozymes in human pulmonary artery and effect of selective PDE inhibitors. Rabe KF; Tenor H; Dent G; Schudt C; Nakashima M; Magnussen H Am J Physiol; 1994 May; 266(5 Pt 1):L536-43. PubMed ID: 7515580 [TBL] [Abstract][Full Text] [Related]
8. Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs. Underwood DC; Kotzer CJ; Bochnowicz S; Osborn RR; Luttmann MA; Hay DW; Torphy TJ J Pharmacol Exp Ther; 1994 Jul; 270(1):250-9. PubMed ID: 8035322 [TBL] [Abstract][Full Text] [Related]
9. Modulation of spasmogen-stimulated Ins(1,4,5)P3 generation and functional responses by selective inhibitors of types 3 and 4 phosphodiesterase in airways smooth muscle. Challiss RA; Adams D; Mistry R; Nicholson CD Br J Pharmacol; 1998 May; 124(1):47-54. PubMed ID: 9630342 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of bronchospasm and ozone-induced airway hyperresponsiveness in the guinea-pig by CDP840, a novel phosphodiesterase type 4 inhibitor. Holbrook M; Gozzard N; James T; Higgs G; Hughes B Br J Pharmacol; 1996 Jul; 118(5):1192-200. PubMed ID: 8818343 [TBL] [Abstract][Full Text] [Related]
11. A comparison of the inhibitory activity of PDE4 inhibitors on leukocyte PDE4 activity in vitro and eosinophil trafficking in vivo. Cooper N; Teixeira MM; Warneck J; Miotla JM; Wills RE; Macari DM; Gristwood RW; Hellewell PG Br J Pharmacol; 1999 Apr; 126(8):1863-71. PubMed ID: 10372831 [TBL] [Abstract][Full Text] [Related]
12. Modulation of eotaxin formation and eosinophil migration by selective inhibitors of phosphodiesterase type 4 isoenzyme. Silva PM; Alves AC; Serra MF; Pires AL; Silva JP; Barreto EO; Cordeiro RS; Jose PJ; Teixeira MM; Lagente V; Martins MA Br J Pharmacol; 2001 Sep; 134(2):283-94. PubMed ID: 11564646 [TBL] [Abstract][Full Text] [Related]
13. Effects of a selective PDE4 inhibitor, D-22888, on human airways and eosinophils in vitro and late phase allergic pulmonary eosinophilia in guinea pigs. Dent G; Poppe H; Egerland J; Marx D; Szelenyi I; Branscheid D; Magnussen H; Rabe KF Pulm Pharmacol Ther; 1998 Feb; 11(1):13-21. PubMed ID: 9802959 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia. Moon E; Lee R; Near R; Weintraub L; Wolda S; Lerner A Clin Cancer Res; 2002 Feb; 8(2):589-95. PubMed ID: 11839681 [TBL] [Abstract][Full Text] [Related]
17. Effects of phosphodiesterase inhibitors on human lung mast cell and basophil function. Weston MC; Anderson N; Peachell PT Br J Pharmacol; 1997 May; 121(2):287-95. PubMed ID: 9154339 [TBL] [Abstract][Full Text] [Related]
18. Pregnancy induces a modulation of the cAMP phosphodiesterase 4-conformers ratio in human myometrium: consequences for the utero-relaxant effect of PDE4-selective inhibitors. Méhats C; Tanguy G; Paris B; Robert B; Pernin N; Ferré F; Leroy MJ J Pharmacol Exp Ther; 2000 Feb; 292(2):817-23. PubMed ID: 10640323 [TBL] [Abstract][Full Text] [Related]
19. Differential inhibition by selective phosphodiesterase inhibitors of antigen, LTC4 and histamine-induced contraction of guinea-pig isolated trachea. Planquois JM; Ruffin-Morin Y; Lagente V; Payne AN; Dahl SG Pulm Pharmacol; 1996 Aug; 9(4):251-8. PubMed ID: 9160414 [TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory and utero-relaxant effects in human myometrium of new generation phosphodiesterase 4 inhibitors. Oger S; Méhats C; Barnette MS; Ferré F; Cabrol D; Leroy MJ Biol Reprod; 2004 Feb; 70(2):458-64. PubMed ID: 14561639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]